Strategic leadership Fingerpaint Group has undergone leadership promotions in 2026 across marketing services, operations, and technology roles, signaling a possible expansion of strategic initiatives, client service scale, and cross-disciplinary offerings that sales teams can leverage to position higher-value partnerships.

Healthcare focus As a medical communications agency serving pharmaceutical and biotech clients with clinical evidence translation, there are ongoing opportunities to upsell integrated medical education, strategic communications, and patient adoption programs to life sciences brands seeking faster market access.

Commercial enablement Recent launch of a commercial support program for a rare brain cancer therapy indicates capability in market access and payer-oriented support, suggestingD potential to cross-sell broader market access, payer strategy, and rapid adoption services to similar oncology and CNS indications.

Tech stack leverage Adoption of multiple marketing and analytics platforms (Eloqua, Amplitude, Sitecore, Contentful) presents cross-sell opportunities to offer expanded MarTech and data-driven marketing services, including attribution, audience segmentation, and multichannel campaign optimization.

Growth momentum Revenue range and recent high-profile hires indicate strong growth trajectory and client demand in niche healthcare advertising, providing a pathway to pursue larger pharma/biotech clients, expand geographic reach, and present evidence of scalable capabilities.